Clinical Trial Update: The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating HLX07 for locally advanced or metastatic cutaneous squamous cell carcinoma, with efficacy and safety data not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• HLX07 (HLX07)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Cutaneous Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN